How to Buy Cronos Group Stock
Cronos Group Inc
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector.
Cronos Group stock last closed at $3.21, up 1.9% from the previous day, and has increased 26.88% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 1.21 percentage points. Cronos Group stock is currently +40.79% from its 52-week low of $2.28, and -6.41% from its 52-week high of $3.43.
As of Aug 18, 2026, there are 368.41M CRON shares outstanding. The market capitalization of CRON is $1.18B. In the last 24 hours, 1.04M CRON shares were traded.
How to Buy Cronos Group Stock
Wondering how to invest in Cronos Group stock? Here's how.
- Choose where to buy Cronos Group stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Cronos Group stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your investment account: Pick your method of payment and add your information.
- Analyze Cronos Group stock: The Cronos Group ticker symbol is CRON. Is Cronos Group stock a good investment? Should you buy shares of CRON? How do CRON's underlying business fundamentals look? Do top analysts think Cronos Group is a good buy? Why has CRON's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if CRON is a good stock to buy).
- Place your CRON trade: Decide if you will purchase CRON shares at the current market price or use a limit order to purchase CRON stock at a given price.
- Keep an eye on your investment in CRON: Create a watchlist to track your position in Cronos Group shares.
Step 1: Choose where to buy Cronos Group stock
You need a brokerage account to access the NASDAQ market and buy CRON stock.
Our preferred brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal details so you can invest in CRON stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to open your new trading account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've filled out your info on one of the best stock apps, you can securely and quickly fund your account:
Watch this video walkthrough for more details depositing money into your new investment account.
Step 4: Analyze Cronos Group stock
After you have decided on the best place to buy Cronos Group stock, it's absolutely critical to evaluate their stock prior to buying, so you actually understand the risk and opportunity.
Overview of key CRON info
CRON Due Diligence Score
WallStreetZen was designed to help everyday investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on CRON's stock page.
Is CRON stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CRON's true value.
Using relative valuations methods:
- CRON could be overvalued based on its P/E ratio of 16.89x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 3.3x
- CRON may be undervalued based on its P/B ratio of 1.11x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 1.64x
- CRON could be undervalued based on its PEG ratio of 0.11x
You can access additional valuation analysis on CRON's stock here.
CRON Financials at a glance
Positive Health Checks:
- Total CRON debt is lower than 5 years ago, relative to shareholder equity.
- CRON has a low debt to equity ratio of 0.06.
- There are more short-term assets than short-term liabilities on the CRON balance sheet.
- CRON profit margin has gone up from 14.2% to 39.1% in the past year.
- There are more short-term assets than long-term liabilities on the CRON balance sheet.
- CRON earnings of $20.28M is not sufficient to cover its interest payments.
- CRON's operating cash flow of $60.05M allows it to safely service it's debt of $1.30M.
CRON Technicals
Is CRON Growing Revenue?
Last year, CRON earnings were $69.98M. Over the past one years, CRON's earnings have gone up by 216.67% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.18%.
Last year, CRON revenue was $179.09M. In the past five year, CRON's revenue has increased by 25.89% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 9.06%.
You can research CRON's earnings and revenue performance here.
Who is buying/selling CRON?
In the last 12 months, executives and large shareholders at CRON have sold more shares than they have bought.
Shannon Buggy, Senior Vice President Global Head of People of CRON, was the latest CRON insider to sell. They sold $25,242.25 worth of CRON shares on May 12, 2026.
Research more about who owns CRON shares here.
Does CRON provide a stable income stream?
No, Cronos Group doesn't provide an income stream by paying out dividends.
CRON Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your CRON trade
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually fine. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, use a limit order.
Hit the Open button and your broker will execute your order.
If you want more assistance investing in stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your investment in CRON
Now that you own some CRON shares, you'll want to keep up with your investment.
Create a watchlist to track your CRON stock.
CRON Feed
How to Buy Stock in Cronos Group
To summarize, here are the 6 steps you need to take to buy Cronos Group stock right now:
- Choose where to buy Cronos Group stock
- Sign up for a brokerage account
- Fund your investment account
- Analyze Cronos Group stock
- Place your CRON trade
- Keep an eye on your investment in CRON
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Cronos Group, click the button below.
Other Content You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.